EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice

Yao Lin, Boshi Wang, Mengling Huang, Justina C Wolters, Marco Demaria iD

Advanced Science · 2026

DOI: 10.1002/advs.202509444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yao Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), University of Groningen (RUG), Groningen, …. Hauptthemen laut MEDLINE: Aging, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, Hevolution Foundation: HF-GRO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is marked by the accumulation of cells expressing the cyclin‐dependent kinase inhibitor p16Ink4a. These p16⁺ cells, largely senescent, contribute to inflammation and tissue dysfunction. While eliminating p16⁺ cells improves healthspan, sex‐specific differences in their burden and clearance remain unclear. Through combined transcriptomic, proteomic, and functional analyses, we reveal distinct sex‐dependent dynamics of p16⁺ cells during aging. Female mice accumulate significantly more p16⁺ cells across multiple tissues, particularly in the liver. In the p16‐3MR model, selective ablation of these cells enhances grip strength, promotes skin regeneration, and reduces liver damage exclusively in females. Multi‐omics profiling shows that p16⁺ cell removal shifts female liver expression toward youthful, health‐associated profiles, marked by improved mitochondrial activity and reduced inflammatory signaling—molecular patterns resembling those induced by longevity interventions such as calorie restriction, rapamycin, and acarbose. Integrative analysis of our and independent datasets identifies a conserved transcriptional network involving Srm, Cd36, and Lrrfip1, suggesting shared mitochondrial–immune regulatory mechanisms. Overall, our findings establish p16⁺ cells as critical yet heterogeneous drivers of tissue aging, uncover sex‐specific differences in their abundance and senolytic responsiveness, and support the development of precision senotherapeutics that consider sex as a key biological variable in aging and rejuvenation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingCyclin-Dependent Kinase Inhibitor p16AnimalsFemaleMiceMaleProteomicsLiverMice, Inbred C57BLCellular SenescenceMultiomics

Stichwörter der Autor:innen

SASPagingcellular senescencep16senolytics

Substanzen

Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), University of Groningen (RUG), Groningen, 9713AV, The Netherlands.
  • Department of Pediatrics, University Medical Center Groningen (UMCG), University of Groningen (RUG), Groningen, 9713AV, The Netherlands.

ORCID-Profile: Marco Demaria

Förderung

  • KWF Kankerbestrijding
  • Hevolution Foundation: HF-GRO

Zitieren

APA

Lin, Y., Wang, B., Huang, M., Wolters, J. C., & Demaria, M. (2026). Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice. Advanced Science. https://doi.org/10.1002/advs.202509444

Vancouver

Lin Y, Wang B, Huang M, Wolters JC, Demaria M. Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice. Advanced Science. 2026. doi:10.1002/advs.202509444

BibTeX
@article{Lin2026,
  author = {Lin, Yao and Wang, Boshi and Huang, Mengling and Wolters, Justina C and Demaria, Marco},
  title = {Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202509444}
}
Kostenlos starten →